HLA-C and neoplasm: Unlike natural T-cell receptors that rely on MHC presentation mechanisms, the CAR structure enables T cells to directly target tumor cell surface antigens toward the specific killing of tumors, which avoids tumor immune escape caused by MHC molecular restriction and downregulation (10).